bpc 157 human clinical trials evidence review safety regulatory status BPC-157 and the Difference Between an Gap and a Cover-Up: What the entire evidence base actually looks like, and the questions to ask next. — WellFounded Regeneration or Risk? A Narrative
Description
The strongest research base is still preclinical rather than large-scale human randomized trials, but the consistency of the findings is one reason BPC-157 has gained so much attention

Morris, M
Learning from successful implementations helps laboratories refine their own protocols

there is no way that I can survive on so few calories

The key principle is slow escalation

There is currently no approved pharmacy or prescription pathway for retatrutide anywhere in the world, so all access remains strictly research use only
